Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-over Comparison of Latanoprost QOD With Dor-tim QAM to Tim-brim-dor-bim(Atoprost) qd or Lat QD With Dor-tim BID

NCT06369077 is registered in ClinicalTrials.gov with CT Glaucoma Associates as lead sponsor.

NCT NCT06369077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-over Comparison of Latanoprost QOD With Dor-tim QAM to Tim-brim-dor-bim(Atoprost) qd or Lat QD With Dor-tim BID
Lead sponsor
CT Glaucoma Associates
Phase
Phase 4
Overall status
Terminated
Start date
April 22, 2024
Completion date
July 30, 2024
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, glaucoma; drugs